^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    Purinergic receptor P2Y12 inhibitor

    Related drugs:
    5d
    ATTEMPT: Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion (clinicaltrials.gov)
    P4, N=3500, Recruiting, Samsung Medical Center | Trial completion date: Dec 2026 --> Dec 2028 | Trial primary completion date: Jun 2025 --> Jun 2027
    Trial completion date • Trial primary completion date
    9d
    Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention (clinicaltrials.gov)
    P4, N=50, Recruiting, University of Florida | Trial completion date: Apr 2026 --> Apr 2027 | Trial primary completion date: Dec 2025 --> Dec 2026
    Trial completion date • Trial primary completion date
    9d
    TAVR-ELECTRO: Electrophysiological Outcomes After Transcatheter Aortic Valve Replacement (clinicaltrials.gov)
    P=N/A, N=1000, Active, not recruiting, Chinese Academy of Medical Sciences, Fuwai Hospital
    New trial
    11d
    CLOPI-SNAP: Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia (clinicaltrials.gov)
    P2, N=230, Not yet recruiting, Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
    New P2 trial
    15d
    Real-world Study on Clinical Characteristics and Risk Factors of Ticagrelor-related Dyspnea (ChiCTR2600116220)
    P=N/A, N=5000, Not yet recruiting, Chinese Academy of Medical Sciences Peking Union Medical College TEDA International Cardiovascular Hospital; Chinese Academy of Medical Sciences Pekin
    New trial
    15d
    Comparative Study of Treatment Strategies for Migraine in Patients with Patent Foramen Ovale (PFO): A Multicenter Randomized Controlled Trial of Transcatheter Closure versus Medical Therapy (ChiCTR2600115896)
    P=N/A, N=150, Recruiting, The Seventh Affiliated Hospital Sun Yat-sen University; The?Seventh?Affiliated?Hospital?Sun?Yat-sen?University
    New trial
    |
    aspirin
    15d
    Low-Dose Versus Standard-Dose Ticagrelor for Secondary Stroke Prevention in Minor Stroke or High-Risk TIA Patients with CYP2C19 Loss-of-Function Alleles (LIGHT): A Randomized Non-Inferiority Trial (ChiCTR2500112634)
    P=N/A, N=1624, Not yet recruiting, Yichang Central People's Hospital; Yichang Central People's Hospital
    New trial
    |
    aspirin
    16d
    ECISBI: Efficacy of Clopidogrel on Incidence of Silent Brain Infarction (clinicaltrials.gov)
    P4, N=134, Active, not recruiting, VA Office of Research and Development | Recruiting --> Active, not recruiting
    Enrollment closed
    23d
    TAPIS: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke (clinicaltrials.gov)
    P3, N=1382, Completed, Beijing Tiantan Hospital | Recruiting --> Completed | Trial completion date: Dec 2026 --> Jan 2026
    Trial completion • Trial completion date
    |
    aspirin
    24d
    BIRDGE 2: The Bridging Antiplatelet Therapy With Cangrelor 2 Study (clinicaltrials.gov)
    P4, N=50, Not yet recruiting, University of Florida | Initiation date: Nov 2025 --> Feb 2026
    Trial initiation date
    24d
    PATH STROKE C: Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE (clinicaltrials.gov)
    P3, N=5138, Recruiting, Sichuan Provincial People's Hospital | Not yet recruiting --> Recruiting
    Enrollment open
    25d
    REPERFUSE: REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts (clinicaltrials.gov)
    P3, N=368, Recruiting, Fondation Ophtalmologique Adolphe de Rothschild | Trial primary completion date: Jun 2026 --> Mar 2026
    Trial primary completion date